LUPO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 15.763
EU - Europa 12.411
AS - Asia 8.976
SA - Sud America 1.283
Continente sconosciuto - Info sul continente non disponibili 289
AF - Africa 167
OC - Oceania 21
Totale 38.910
Nazione #
US - Stati Uniti d'America 15.503
RU - Federazione Russa 4.088
SG - Singapore 3.750
GB - Regno Unito 2.969
CN - Cina 2.626
BR - Brasile 1.029
IT - Italia 1.028
SE - Svezia 929
VN - Vietnam 772
DE - Germania 761
FR - Francia 747
IE - Irlanda 684
FI - Finlandia 657
HK - Hong Kong 648
KR - Corea 316
UA - Ucraina 219
BD - Bangladesh 211
IN - India 124
CA - Canada 119
AR - Argentina 94
JP - Giappone 76
ID - Indonesia 71
TR - Turchia 64
MX - Messico 55
IQ - Iraq 53
BE - Belgio 50
NL - Olanda 48
AT - Austria 41
NG - Nigeria 41
EC - Ecuador 40
ZA - Sudafrica 38
CO - Colombia 36
ES - Italia 34
PL - Polonia 32
VE - Venezuela 28
IL - Israele 25
PK - Pakistan 23
UZ - Uzbekistan 23
MA - Marocco 22
SA - Arabia Saudita 20
AU - Australia 19
PH - Filippine 19
JM - Giamaica 18
PY - Paraguay 18
EG - Egitto 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
MY - Malesia 16
TH - Thailandia 15
HN - Honduras 14
CZ - Repubblica Ceca 13
AZ - Azerbaigian 12
CR - Costa Rica 11
EU - Europa 11
GR - Grecia 11
LT - Lituania 11
JO - Giordania 10
KZ - Kazakistan 10
TN - Tunisia 10
CH - Svizzera 9
NP - Nepal 9
RO - Romania 9
BH - Bahrain 8
DK - Danimarca 8
KE - Kenya 8
NI - Nicaragua 8
PA - Panama 8
RS - Serbia 8
AL - Albania 7
BO - Bolivia 7
HR - Croazia 7
PE - Perù 7
IR - Iran 6
KG - Kirghizistan 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
CG - Congo 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
LV - Lettonia 5
SN - Senegal 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
DZ - Algeria 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
TW - Taiwan 4
AM - Armenia 3
EE - Estonia 3
GY - Guiana 3
LK - Sri Lanka 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 38.589
Città #
Southend 2.455
Singapore 1.992
Jacksonville 1.893
Ashburn 1.752
Chandler 1.444
San Jose 1.323
Moscow 1.246
Woodbridge 901
Dallas 824
Ann Arbor 714
Dublin 678
Hong Kong 640
Houston 550
Council Bluffs 466
Verona 400
Beijing 383
The Dalles 378
Wilmington 286
Lawrence 269
Princeton 268
New York 255
Los Angeles 222
Ho Chi Minh City 199
Jinan 198
Nanjing 173
Shenyang 166
Buffalo 165
Hanoi 148
Santa Clara 134
Helsinki 132
Boardman 119
Tianjin 115
Hebei 106
São Paulo 106
Dong Ket 101
Columbus 91
Milan 89
Sindelfingen 89
Annandale 80
Tokyo 72
Ningbo 66
Changsha 64
Haikou 63
Orem 63
Guangzhou 62
Zhengzhou 62
Redondo Beach 61
Nanchang 58
Chicago 55
Munich 55
Jiaxing 52
Seattle 52
Brussels 50
Hangzhou 50
Lancaster 48
San Francisco 44
Taizhou 44
Falls Church 41
Seoul 41
Atlanta 40
Philadelphia 40
Phoenix 40
Rome 40
Abuja 39
Taiyuan 38
Jakarta 37
Brooklyn 36
Toronto 36
Norwalk 35
Rio de Janeiro 35
Lanzhou 33
London 32
Denver 31
Montreal 30
Providence 30
Washington 30
Chennai 29
Nuremberg 29
Frankfurt am Main 28
Turku 28
Las Vegas 27
Auburn Hills 26
Vienna 26
Warsaw 26
Detroit 25
Kent 25
Amsterdam 22
Da Nang 22
Haiphong 22
Baghdad 21
Charlotte 21
Fairfield 21
Johannesburg 21
Quito 21
Redmond 21
Fuzhou 20
Venice 19
Brasília 18
Mumbai 18
Redwood City 18
Totale 23.809
Nome #
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 305
125I-iothalamate and creatinine clearances in patients with chronic renal diseases 295
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 271
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 264
Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications 260
Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 234
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study. 231
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 221
Cutaneous plasmacytoma in a hemodialysis patient. 219
Terapia della glomerulonefrite membrano proliferativa. 217
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. 215
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. 215
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 214
Outcomes of the surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for hemodialysis 213
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 211
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 211
14-year experience with the double-cuff straight Tenckhoff catheter 210
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin 210
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study 209
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 209
Alterations in renal tubular sodium and water transport in polycystic kidney disease 205
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 205
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 203
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 201
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 201
mTOR inhibitors and renal allograft: Yin and Yang. 196
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 195
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 195
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 193
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 193
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 193
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 192
99mTc-Ca-gluconate renal scintigraphy in patients with chronic renal failure 191
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 191
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 191
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 190
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation 189
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 189
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 187
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 187
The impact of pruritus on quality of life of patients undergoing dialysis: A single-center cohort study 187
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 186
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 186
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 182
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 182
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 182
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 180
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 179
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 178
Bedside Screening for Fistula Stenosis Should Be Tailored to the Site of the Arteriovenous Anastomosis 178
Acute changes in renal function in IgA nephropathy 177
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 177
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 177
Rapporti tra adattamento, qualità di vita e supporto familiare, sociale nel paziente in trattamento dialitico. [Dialysis, adaptation, quality of life, and family support.] 176
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 176
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 175
Assessment of physical performance and body composition in male renal transplant patients 175
In search of an optimal bedside screening program for arteriovenous fistula stenosis 174
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 174
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 173
3 years' experience in the prevention of recurrent calcic nephrolithiasis 172
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 172
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 172
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 171
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function 170
Altered thyroid in dialysed uremic patients 170
A validated model of disease progression in IgA nephropathy. 170
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 170
Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey. 169
Unusual renal presentation of Fabry disease in a female patient. 169
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 169
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 168
Renal lesions after unilateral ureterosigmoidostomy in the rabbit: preliminary results 165
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 165
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 165
Post-renal transplant pregnancy: a project to plan carefully 163
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 163
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 162
Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension 161
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group 161
mTOR Inhibition Role in Cellular Mechanisms 161
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 161
CORREZIONE ANGIOPLASTICA O CHIRURGICA DELLA STENOSI NELLE FISTOLE ARTEROVENOSE? UNO STUDIO PROSPETTICO CONTROLLATO 160
Procalcitonin values after dialysis is closely related to type of dialysis membrane 160
Mitochondria: a new therapeutic target in chronic kidney disease. 160
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 160
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 159
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure 158
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 158
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 158
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 158
Cutaneous plasmacytoma in a hemodialysis patient. 157
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 157
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 157
Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics 156
Atherosclerosis and cardiovascular risk factors in CAPD 156
Light and electron microscopic findings in five cases of cryoglobulinemic glomerulonephritis 155
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 155
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 155
Renal tubular defects in recurring bilateral nephrolithiasis 154
Totale 18.597
Categoria #
all - tutte 131.419
article - articoli 120.110
book - libri 0
conference - conferenze 5.234
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.075
Totale 262.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.200 0 0 0 178 64 52 39 113 88 50 150 466
2022/20234.371 328 426 471 662 419 1.100 53 267 444 23 121 57
2023/20241.717 99 176 163 198 235 231 27 117 16 76 261 118
2024/20254.810 312 351 174 825 225 160 194 269 729 290 375 906
2025/202613.623 1.060 696 913 2.121 3.199 961 1.435 754 899 784 351 450
2026/20271.980 218 384 632 746 0 0 0 0 0 0 0 0
Totale 38.910